How a Supreme Court fight over fish oil could raise your prescription drug costs
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Original Source
Read the full article at Npr →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.